Timothy L Frankel, MD

Timothy Frankel
Professor of Surgical Oncology
Professor of Surgery
Co-Director of the Rogel and Blondy Center for Pancreatic Cancer
Rogel Cancer Center
Medical School
[email protected]
Available to mentor
Timothy L Frankel, MD
Timothy Frankel
Professor
  • About
  • Links
  • Qualifications
  • Center Memberships
  • Research Overview
  • Recent Publications
  • Manage Your Profile

  • About

    Dr. Timothy L. Frankel is a faculty member within the Section of General Surgery at the University of Michigan. He graduated Magna Cum Laude from Connecticut College in 2000 with a B.A. in Physics and was elected into Phi Beta Kappa. He earned his medical degree from George Washington University in 2004 and was inducted into the Alpha Omega Alpha Honor Medical Society. He completed a residency in General Surgery at the University of Michigan in 2011 during which time he spent two years at the National Cancer Institute studying tumor immunology and genetic engineering. He developed techniques to genetically modify peripheral blood lymphocytes allowing them to more effectively target tumors for destruction. His work resulted in multiple publications and awards including the James Crudup Surgical Research Award. After completion of residency, he completed a two-year surgical oncology fellowship at Memorial Sloan-Kettering Cancer Center in New York.

    Clinical Interests
    • His clinical interests are in the treatment of gastrointestinal malignancies including cancers of the liver, pancreas and stomach. He has published multiple clinical papers on techniques in liver resection for colorectal metastases. He is the surgical lead for the liver tumor program at the Ann Arbor VA and has doubled the volume of liver surgery since joining. He is also establishing multidisciplinary cancer clinics to accelerate work-up and treatment of veterans with cancer. He serves as the Chair of the Commission on Cancer certified Cancer Program and was recently named Director of Comprehensive Cancer Care at the Ann Arbor VA. This role is tasked with monitoring the quality of cancer care provided at the institution and shaping policy related to the treatment of cancer patients. He has formed a cancer care navigation program staffed with providers who facilitate care of patients with newly diagnosed or suspicious tumors guiding them through evaluation and treatment.

    Links

    • https://medresearch.umich.edu/labs-departments/labs/frankel-lab
    • twitter

    Qualifications

    • Fellow
      Memorial Sloan Kettering Cancer Center, Surgery, New York, United States
      2011 - 2013
      Clinical Fellowship
    • Resident
      University of Michigan Medical School, Surgery, Ann Arbor, United States
      2004 - 2011
      Residency
    • Research Fellow, Surgical Oncology
      National Cancer Institute, Surgery, Bethesda, United States
      2007 - 2009
      Postdoctoral Fellowship

    Center Memberships

    • Center Member
      e-Health and Artificial Intelligence Initiative
    • Center Member
      Rogel Cancer Center

    Research Overview

    • Inflammation induced pancreatic cancer
    • Understanding spatial relationships of immune cells in the tumor microenvironment
    • Understanding the role of adipose derived progenitor cells in promoting pancreatic cancer formation in diabetics

    Recent Publications

    See All Publications
    • Journal Article
      Informed spatially aware patterns for multiplexed immunofluorescence data
      Bhadury S, Peruzzi M, Acharyya S, Eliason J, Di Magliano MP, Frankel TL, Ravikumar V, Krishnan S, Rao A. Scientific Reports, 2026 Dec 1; 16 (1): DOI:10.1038/s41598-026-35341-8
      PMID: 41521220
    • Journal Article
      Targeting CCR1 remodels the tumor microenvironment and relieves immune suppression in pancreatic cancer.
      Zhang Y, Kadiyala P, Yan W, Brown K, Avritt FR, Donahue KL, Procario MC, Okoye JO, Giridharan T, Elhossiny AM, Espinoza CE, Awad D, Lasse Opsahl EL, Medina-Cabrera PI, Velez-Delgado A, Menjivar RE, Yang OA, Yang S, He X, Gupta S, Tariq R, Brandt AR, Wang X, denDekker A, Nwosu ZC, Carpenter ES, Courtney AH, Bednar F, Frankel TL, Lyssiotis CA, Zheng B, Kryczek I, Pasca di Magliano M. Cancer Immunol Res, 2026 May 28; DOI:10.1158/2326-6066.CIR-25-1300
      PMID: 42207977
    • Journal Article
      Asynchronous evolution of epithelium and stroma differentiates precursor lesions from pancreatic cancer.
      Elhossiny AM, Kadiyala P, Okoye JO, Hiraki HL, Procario MC, Giridharan T, Watkoske HR, Tannus Ruckert M, Wang J, Griffith BD, Bray AW, Mills JN, Espinoza CE, Zeller J, Peterson N, Bednar F, Zhang Y, Rao A, Lyssiotis CA, Szczepanski JM, Shi J, Deshpande A, Maitra A, Fertig EJ, Carpenter ES, Frankel TL, Pasca di Magliano M. Cancer Discov, 2026 May 21; DOI:10.1158/2159-8290.CD-25-2001
      PMID: 42165710
    • Journal Article
      296b LONGITUDINAL ANALYSIS OF MATCHED PATIENT BIOSPECIMENS REVEALS NEURAL REPROGRAMMING OF CANCER-ASSOCIATED FIBROBLASTS FOLLOWING CHEMOTHERAPY IN PANCREATIC DUCTAL ADENOCARCINOMA
      Henstridge A, Sahai V, Peterson N, Machicado JD, Kwon R, Schulman AR, Wamsteker E-J, Philips GM, Menees SB, Xia JY, Hogenson T, Shi J, Frankel T, Bednar F, Di Magliano MP, Lyssiotis CA, Truty MJ, Fernandez-Zapico ME, Carpenter E. Gastrointestinal Endoscopy, 2026 May 3; 103 (5): s - 2850. DOI:10.1016/s0016-5107(26)06672-1
    • Journal Article
      296b LONGITUDINAL ANALYSIS OF MATCHED PATIENT BIOSPECIMENS REVEALS NEURAL REPROGRAMMING OF CANCER-ASSOCIATED FIBROBLASTS FOLLOWING CHEMOTHERAPY IN PANCREATIC DUCTAL ADENOCARCINOMA
      Henstridge A, Sahai V, Peterson N, Machicado JD, Kwon R, Schulman AR, Wamsteker E-J, Philips GM, Menees SB, Xia JY, Hogenson T, Shi J, Frankel T, Bednar F, Di Magliano MP, Lyssiotis CA, Truty MJ, Fernandez-Zapico ME, Carpenter E. Gastroenterology, 2026 May 7; 170 (6): s - 2850. DOI:10.1016/s0016-5085(26)06741-7
    • Journal Article
      Tumor cell death by ferroptosis contributes to an immunosuppressive tumor microenvironment in syngeneic murine models of cancer.
      Mbah NE, Sutton D, Hong HS, Singhal R, Menjivar RE, Perricone MD, Giza H, Sajjakulnukit P, Myers AL, Nwosu ZC, Alektiar JM, Lin J, Long D, Andren AC, Zhang L, Crawford HC, Frankel TL, Pasca di Magliano M, Franchi L, Shah YM, Lyssiotis CA. Cancer Metab, 2026 Apr 4; 14 (1): DOI:10.1186/s40170-026-00428-3
      PMID: PMC13072669
    • Journal Article
      Elevated T Cell Immunoreceptor with Ig and ITIM Domains (TIGIT) Expression and Immune Cell Dysfunction Characterize Complex Proteins Associated With SET1 (COMPASS)–Like Complex Gene–Mutated Pancreatic Ductal Adenocarcinoma (PDAC)
      Zhang S, Daniels ER, McGue J, Sudharshan R, Kim HC, Thomas DG, Krishnan S, Frankel TL, Hissong E, Rao A, Assarzadegan N, Shi J. Modern Pathology, 2026 Apr 1; 39 (4): DOI:10.1016/j.modpat.2026.100972
      PMID: 41638576
    • Journal Article
      Longitudinal Analysis of Matched Patient Biospecimens Reveals Neural Reprogramming of Cancer-Associated Fibroblasts Following Chemotherapy in Pancreatic Cancer.
      Henstridge AZ, Arya N, Elhossiny AM, Kadiyala P, Branch G, Sahai V, Peterson N, Machicado JD, Kwon R, Schulman AR, Wamsteker E, Philips G, Menees SB, Xia JY, Hogenson TL, Rao A, Shi J, Frankel TL, Bednar F, Pasca di Magliano M, Lyssiotis CA, Truty MJ, Fernandez-Zapico ME, Carpenter ES. bioRxiv, 2026 Feb 11; DOI:10.64898/2025.12.01.691614
      PMID: PMC12822592

    Featured News & Stories

    yellow black purple red cell in middle mostly black
    Health Lab

    Study sheds light on how early pancreas lesions become cancerous

    Why many precursor lesions never develop into pancreatic cancer, according to findings from Michigan Medicine.
    Susan and Richard Rogel stand with Dr. Eric Fearon the director of the Rogel Cancer Center as well as the leaders of the new Rogel and Blondy Center for Pancreatic Cancer Research
    News Release

    Ribbon-cutting for new pancreatic cancer program

    The Rogel and Blondy Center for Pancreatic Cancer was officially launched with a special ribbon-cutting ceremony on the sixth floor of the Rogel Cancer Center.
    microscopic image with one on left saying untreated and one right saying TCDD treated. They are lit up bright green and some blue and a little red on the right
    Health Lab

    Study shows how smoking drives pancreatic cancer

    Why smokers have a higher chance of developing pancreatic cancer and why they tend to have worse outcomes than nonsmokers, according to a new study by University of Michigan Health Rogel Cancer Center.
    outline drawing of pancreas on beige screen with green orange yellow and pink
    Health Lab

    Avoiding recovery delays with hospitalized pancreatitis

    Acute pancreatitis is among the most common gastrointestinal conditions requiring inpatient hospital care in the United States. Balancing the signaling of the interleukin-22 protein and interleukin-22 binding protein is crucial to recovery from acute and chronic pancreatitis.
    A scientific diagram of immunofluoresence
    Department News

    Donor pancreas tissue helps define ‘new normal’ in pancreatic cancer research

    A research partnership between Michigan Medicine and Gift of Life Michigan has revealed a new pathway to understanding the progression of pancreatic cancer.